期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Pharmaceutics LetPub Score 7.5
50 ratings
Rate
Reputation 8.3 Influence 6.5 Speed 9.6 | ||||||||||||||||
期刊簡稱 | PHARMACEUTICS | ||||||||||||||||
ISSN | 1999-4923 | ||||||||||||||||
h-index | 32 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 12.20%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.mdpi.com/journal/pharmaceutics | ||||||||||||||||
在線稿件提交 | https://login.mdpi.com/login?_target_path=https%3A%2F%2Fsusy.mdpi.com%2Fuser%2Flogin%3FauthAll%3Dtrue | ||||||||||||||||
開放訪問 | Yes | ||||||||||||||||
出版商 | MDPI (Basel, Switzerland) | ||||||||||||||||
主題領域 | Pharmacology, Toxicology and Pharmaceutics | ||||||||||||||||
出版國/地區 | Switzerland | ||||||||||||||||
發行頻率 | |||||||||||||||||
創刊年 | 2009 | ||||||||||||||||
每年文章數 | 2749每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 99.64% | ||||||||||||||||
OA Related Info | APC: Yes( CHF2900; ) APC waiver:Check Notes Other charges: No Keywords: pharmacokinetics Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1999-4923%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 16.41 Day(s) 來自作者的數據: 11 Weeks | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Pharmaceutics] 的評論 | 撰寫評論 |
作者: 罗汉沈然 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-06 19:43:02 評論於 How long does the general review process take?(0) 讚! | 罗汉沈然 |
作者: 天山含芙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-04 16:27:49 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: Faster review process(0) 讚! | 天山含芙 |
作者: 差不多就好 領域: 生物学 審稿時間: 4.0 month(s) 結果: 拒稿 撰寫評論 |
2023-12-28 22:32:44 評論於 Demoted to a third-tier journal of the Chinese Academy of Sciences, what do you think?(0) 讚! | 差不多就好 |
作者: 风陵孤双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-30 23:06:11 評論於 Have you voted?(0) 讚! | 风陵孤双 |
作者: Rod Theresa 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-01 12:08:32 評論於 Is the magazine very strict about the manuscript format?(0) 讚! | Rod Theresa |
作者: 一吃就胖小萌阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-18 13:48:02 評論於 It has been almost a month since the submission, and it is still under review. What should I do?(0) 讚! | 一吃就胖小萌阳 |
作者: 昭巫晶燕 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-16 19:47:41 評論於 How to find the journal's official website?(0) 讚! | 昭巫晶燕 |
作者: 一吃就胖小萌阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-03 09:22:37 評論於 Hello, how is your article coming along now?(0) 讚! | 一吃就胖小萌阳 |
作者: gren 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-10-09 21:11:09 評論於 The reviewer is very responsible and has provided very constructive comments. Many of them are very pertinent and have indeed improved the quality of the manuscript. The editor is also very diligent and responsible. The efficiency is more than double that of the usual magazines.(0) 讚! | gren |
作者: 凌波凌熙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-05 15:30:42 評論於 Hello, may I ask if Nanoparticles combined therapy can cure this disease?(0) 讚! | 凌波凌熙 |
作者: 凌波凌熙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-05 13:01:56 評論於 How long did it take for your paper to be reviewed?(0) 讚! | 凌波凌熙 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:56:58 評論於 Different journals may have different requirements, so it is necessary to follow the specific requirements of the journal to complete the submission(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:55:39 評論於 Journal websites will have author guidance, with detailed formatting requirements listed on the page(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 23:45:19 評論於 Are the format requirements the same for each journal?(0) 讚! | 八坂篷蔚 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 13:11:28 評論於 How to find the format requirements for a specific journal?(0) 讚! | 八坂篷蔚 |
作者: 销魂天赐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-04 17:05:50 評論於 It has been pending review for a week, and there has been no change. Is it a bad sign? ?(0) 讚! | 销魂天赐 |
作者: 德温贝儿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-25 13:05:36 評論於 Review speed: 2.0 Experience sharing: The boss in the group is the editor of the sub-section, but it doesn't seem to be very useful. The editor directly gives opinions to two reviewers, one with a mediocre attitude and one more positive. Overall, the first review comments are given very quickly, receiving first review comments in about a month. After revising, they were accepted. The editorial office is very transparent, and all reviewer comments can be seen eventually. Good impression. Also saw articles by Chinese authors, and the speed is also similar. Generally, it is indeed easier to publish articles in Europe's schools than in China. Hope that Chinese journals will continue to improve in the future(0) 讚! | 德温贝儿 |
作者: 盖尔莫尔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-12-04 10:31:28 評論於 Review speed: 1.0 Experience sharing: Journals not yet dominated by the Chinese are very fast in review speed, with very fair comments from reviewers, transparent review processes, and are relatively formal open access journals with high cost performance in the CSCI Zone II(0) 讚! | 盖尔莫尔 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us